Transfection of CD40 in a human oral squamous cell carcinoma keratinocyte line upregulates immune potency and costimulatory molecules
暂无分享,去创建一个
P. Speight | S. Whawell | P. Speight | A. Barrett | S. Whawell | M. Villarroel Dorrego | S.A. Whawell
[1] M. V. Dorrego,et al. Expresión de las moléculas del Complejo Mayor de Histocompatibilidad clase II y moléculas co-estimuladoras en carcinomas orales in vitro , 2005 .
[2] W. Boscardin,et al. Expression and Function of CD28 on Epstein-Barr Virus-Positive B Cell Lines and AIDS-Associated Non-Hodgkin’s Lymphoma Cell Lines , 2003, Tumor Biology.
[3] S. Khoury,et al. T cell costimulatory pathways: blockade for autoimmunity , 2003, Expert opinion on biological therapy.
[4] R. Watson,et al. Oral mucosal keratinocytes express RANTES and ICAM‐1, but not interleukin‐8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings , 2003, Clinical and experimental dermatology.
[5] R. Peach,et al. In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function1 , 2002, The Journal of Immunology.
[6] J. Gribben,et al. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity. , 2001, International journal of oncology.
[7] D. Sheppard,et al. Expression of the αvβ6 Integrin Promotes Migration and Invasion in Squamous Carcinoma Cells , 2001 .
[8] F. Fortune,et al. Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[9] N. Park,et al. Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity. , 2000, International journal of oncology.
[10] D. Adams,et al. CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily , 2000, Molecular and Cellular Biology.
[11] P. Vandenabeele,et al. TTRAP, a Novel Protein That Associates with CD40, Tumor Necrosis Factor (TNF) Receptor-75 and TNF Receptor-associated Factors (TRAFs), and That Inhibits Nuclear Factor-κB Activation* , 2000, The Journal of Biological Chemistry.
[12] S. Lang,et al. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death. , 2000, Cellular immunology.
[13] C. Van Waes,et al. IL‐12‐ and IL‐2‐induced tumor regression in a new murine model of oral squamous‐cell carcinoma is promoted by expression of the CD80 co‐stimulatory molecule and interferon‐γ , 2000, International journal of cancer.
[14] K. Gulabivala,et al. The preparation of periapical lesions for flow cytometry. , 2000, International endodontic journal.
[15] L. Cavacini,et al. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] C. Van Waes,et al. Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous‐cell carcinoma , 1999, International journal of cancer.
[17] E. Prens,et al. Interferon‐γ‐induced ICAM‐1 and CD40 expression, complete lack of HLA‐DR and CD80 (B7.1), and inconsistent HLA‐ABC expression in basal cell carcinoma: a possible role for interleukin‐10? , 1999 .
[18] L. Vogel,et al. CD40 and its crucial role as a member of the TNFR family. , 1998, Seminars in immunology.
[19] J. Grousson. Functional Relevance of CD40 Expression in Human Epidermis , 1998, Cell Biology and Toxicology.
[20] D. Schmitt,et al. Effects of CD40 ligation on human keratinocyte accessory function , 1998, Archives of Dermatological Research.
[21] A. Gaspari,et al. Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth. , 1997, The Journal of investigative dermatology.
[22] J. Banchereau,et al. Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.
[23] N. Hayashi,et al. Expression of costimulatory molecules B7‐1 (CD80) and B7‐2 (CD86) on human hepatocellular carcinoma , 1997, Hepatology.
[24] J. Banchereau,et al. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. , 1997, Journal of immunology.
[25] M. Mori,et al. The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: its regulation by interferon γ and interleukin-10 , 1996, Cancer Immunology, Immunotherapy.
[26] E. Clark,et al. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. , 1996, Journal of immunology.
[27] R. Flavell,et al. The Role of CD40 Ligand in Costimulation and T‐Cell Activation , 1996, Immunological reviews.
[28] H. Otten,et al. Alloantigen‐specific T‐cell anergy induced by human keratinocytes is abrogated upon loss of cell‐cell contact , 1996, Immunology.
[29] M. Thornhill,et al. Cytokine regulation of major histocompatibility complex antigen expression by human oral and skin keratinocytes. , 1996, Archives of oral biology.
[30] K. Sell,et al. Induction of Autologous Tumor‐Specific Cytotoxic T‐Lymphocyte Activity Against a Human Renal Carcinoma Cell Line by B7–1 (CD80) Costimulation , 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[31] L. Chen,et al. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. , 1995, Journal of immunology.
[32] L. Davis,et al. The CD40 ligand expressed by human B cells costimulates B cell responses. , 1995, Journal of immunology.
[33] A. Gaspari,et al. Human keratinocytes regulate their expression of B7/BB-1 antigen by a unique, calcium-dependent mechanism. , 1995, The Journal of investigative dermatology.
[34] A. Durandy,et al. Recombinant Soluble Trimeric CD40 Ligand Is Biologically Active * , 1995, The Journal of Biological Chemistry.
[35] J. Bonnefoy,et al. CD40 ligand is functionally expressed on human eosinophils , 1995, European journal of immunology.
[36] L. Glimcher,et al. Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice , 1995, The Journal of experimental medicine.
[37] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[38] B. Shroot,et al. A novel in vitro model for the study of human keratinocyte/leucocyte interactions under autologous conditions , 1993, The British journal of dermatology.
[39] C. Elmets,et al. In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermis. , 1993, The Journal of investigative dermatology.
[40] S. Kojima,et al. The Expression of Invasive Behavior of Differentiated Squamous Carcinoma Cell Line Evaluated by an in vitro Invasion Model , 1993, Japanese journal of cancer research : Gann.
[41] P. Linsley,et al. Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. , 1993, The Journal of investigative dermatology.
[42] P. Farthing,et al. Langerhans cell distribution and keratinocyte expression of HLADR in oral lichen planus. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[43] S. Rice,et al. Production of a Suppressor of Lymphocyte Proliferation by Two Human Oral Carcinoma Cell Lines , 1992, Scandinavian journal of immunology.
[44] C. Scully,et al. MHC antigen expression in human oral squamous carcinoma cell lines , 1991, The Journal of pathology.
[45] C. Scully,et al. Effect of IFN–γon the expression of MHC class I and class II antigens in a human malignant oral epithelial cell line , 1991 .
[46] P. Farthing,et al. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[47] S. Rice,et al. The expression of MHC antigens on cultured oral keratinocytes and relationship to malignancy. , 1988, British journal of experimental pathology.
[48] N. Savage,et al. Expression of class I and class II major histocompatibility complex antigens on oral mucosal epithelium. , 1987, Journal of oral pathology.
[49] T. Luger,et al. Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon Stimulation with γ-Interferon , 1985 .
[50] T. Merigan,et al. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. , 1984, The Journal of investigative dermatology.
[51] R. Jonsson,et al. Maintained CD40 and loss of polarised CD40 ligand expression in oral squamous cell carcinoma. , 2001, Anticancer research.
[52] I. Fernández,et al. Expression of intercellular adhesion molecule 1 (ICAM-1) in oral squamous cell carcinoma. , 2000, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.
[53] B. Wollenberg,et al. Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration. , 1999, Archives of otolaryngology--head & neck surgery.
[54] R. Flavell,et al. CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.
[55] D. Schmitt,et al. CD40 expression in epidermal tumors. , 1997, Anticancer research.
[56] J. B. Matthews,et al. Inflammatory cell infiltrate associated with primary and transplanted tumours in an inbred model of oral carcinogenesis. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[57] C. Scully,et al. Effect of IFN-gamma on the expression of MHC class I and class II antigens in a human malignant oral epithelial cell line. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[58] T. Merigan,et al. Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes. , 1985, Journal of interferon research.
[59] T. Luger,et al. Human epidermal cells synthesize HLA-DR alloantigens in vitro upon stimulation with gamma-interferon. , 1985, The Journal of investigative dermatology.